POm E-stimulation before whisker stimulus does not decrease cortical response magnitude and duration when AGA is applied in L1. by Carlos Castejon (2182382)

Fluorofenidone decreased p22^phox expression in the kidney of <i>db/db</i> mice at earlier stages of DN development. by Xuan Xiong (649607)

Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

“…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”

Quercetin decreases proliferation (A) and induces apoptosis (B) in cultured PASMC from control rats. by Daniel Morales-Cano (668199)

Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. by Hyung-Ran Kim (532404)

Proteomic identification of substrates for seven-beta-strand MTases. by Tadahiro Shimazu (619411)

Mammalian METTL10 is an EF1A1 KMT. by Tadahiro Shimazu (619411)

Chow-fed <i>Mecp2</i> KO mice have significantly increased WAT mass and serum leptin, and decreased rotarod performance. by Min Jung Park (642131)

Decreased ovary size and defective oogenesis following specific targeting of <i>Hdac2</i> and reduction of <i>Hdac1</i> in oocytes. by Pengpeng Ma (389371)

Sildenafil decreases intestinal transit time in a DSS-recovery model of IBS. by Sarah K. Sharman (3966476)

Nitrotyrosination of gp34 significantly decreases both its binding affinity and stabilization capacity of the H-2K^b complex. by Chaithanya Madhurantakam (329447)

MSC treatment does not affect chronic LPS-induced decreased lung function. by P. Padmini S. J. Khedoe (4436458)

DnaK inhibits protein synthesis in vivo and in vitro. by Carissa Chan (18310140)

Genomic inactivation of the <i>PIWI</i> gene in <i>L. infantum</i> and <i>L. major</i> strains leads to a decrease in amastigote growth and disease pathology. by Prasad K. Padmanabhan (85254)

DnaK’s ATPase activity is stimulated by ribosomes and required to reduce protein synthesis. by Carissa Chan (18310140)

All data points from Fig 2. by Sara Hijazi (21656615)

“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”

All data points from Fig 8. by Sara Hijazi (21656615)

“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”

All data points from Fig 3. by Sara Hijazi (21656615)

“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”

All data points from Fig 1. by Sara Hijazi (21656615)

“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”

All data points from Fig 4. by Sara Hijazi (21656615)

“…Following a remyelination period of 5 weeks, PV interneuron properties were only partially recovered, suggesting that transient juvenile demyelination leads to long-lasting impairments of PV interneuron function. …”